Bayer AG

• A study to learn about how different drugs interact with each drug in a new 7-drug mixture as they move into, through, and out of the body i… Pending
  2023-504870-39-00 Phase I (Other) 1 country
• (22597) A study to learn about how safe nitroglycerin is and how it affects the body when taken along with nurandociguat in people with coro… Pending
  2025-522335-34-00 Phase I (Other) 2 countries
• A study to learn how safe nurandociguat is when taken with sildenafil in men with arterial hypertension. Pending
  2025-522336-14-00 Phase I (Other) 1 country
• A study to learn about how a new nurandociguat tablet is absorbed and processed in the body compared to an old tablet and how food affects t… Pending
  2025-524176-36-00 Phase I (Other) 1 country
• A study to learn more about how safe finerenone is, when it is taken for a longer time with standard treatment, in children and young adults… Recruiting
  2024-519830-22-00 Phase III 13 countries FINERENONE
• A study to learn about how safe BAY 3389934 is, its suitable dose, and how it affects the participants with sepsis and coagulopathy Recruiting
  2024-515635-30-00 Phase I (Other) 4 countries
• A first-in-human study to learn how safe BAY 3713372 is and how it works in participants with MTAP-deleted solid tumors Recruiting
  2025-520623-24-00 Phase I (FiH) 7 countries BAY 3713372
• A study to learn how safe the study treatment actinium-225-macropa-pelgifatamab (BAY3546828) is, how it affects the body, how it moves into,… Recruiting
  2022-502623-22-00 Phase I 4 countries
• First in human study of BAY2927088 in participants who have advanced non-small cell lung cancer (NSCLC) with mutations in the genes of epide… Recruiting
  2023-503795-24-00 Phase I (FiH) 7 countries
• A study to learn more about the safety and effects of a new blood-thinning medicine, given alone and together with another blood-thinner, in… Recruiting
  2025-524043-12-00 Phase I (Other) 1 country
• A study to learn about the amount of asundexian in the blood and the effect of food on its levels when healthy participants take it as adult… Recruiting
  2025-523677-41-00 Phase I (Other) 1 country ASUNDEXIAN
• A study to learn about how well BAY 3401016 works in adults with Alport syndrome Recruiting
  2024-516471-33-00 Phase II 7 countries BAY 3401016
• A study to learn more about how well finerenone works, how safe it is, and how it moves into, through, and out of the body compared to place… Recruiting
  2024-519829-38-00 Phase III 13 countries FINERENONE
• A first-in-human study to learn about how safe BAY 3620122 is, how much of it gets absorbed in the blood, and how it affects the body of hea… Recruiting
  2025-523301-15-00 Phase I 1 country
• A first-in-human study to learn about the safety of BAY 3547926 and how well it works in participants with advanced liver cancer Recruiting
  2024-516615-25-00 Phase I 4 countries
• A study to learn more about how well treatment with sevabertinib (BAY2927088) tablets works and how safe it is in participants who have a so… Recruiting
  2024-517419-62-00 Phase II 4 countries 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,…
• A study to learn BAY 3498264 when given alone or together with sotorasib in participants who have advanced solid cancers with specific genet… Recruiting
  2024-513300-34-00 Phase I 3 countries
• A study to learn more about how well sevabertinib works and how safe it is compared with standard treatment, in participants who have advanc… Recruiting
  2024-511319-91-00 Phase III 18 countries 3-(3-CHLORO-2-METHOXYANILINO)-2-{3-[(2S)-1,4-DIOXAN-2-YLMETHOXY]PYRIDIN-4-YL}-1,…
• A study to learn more about how safe the study treatment finerenone is in long-term use when taken with an ACE inhibitor or angiotensin rece… Recruiting
  2023-504885-50-00 Phase III 17 countries FINERENONE
• A study of continued treatment with regorafenib in participants with solid tumors who have participated in other Bayer studies Ended
  2023-507084-19-00 Phase II 2 countries REGORAFENIB
• A first-in-human study to learn about how safe BAY 3375968 is, how it moves into, through, and out of the body, and to find its best dose wh… Ended
  2023-505594-32-00 Phase I 3 countries
• A study to compare the study treatment darolutamide in combination with androgen deprivation therapy (ADT) to placebo in combination with AD… Ended
  2022-501343-33-00 Phase III 14 countries DAROLUTAMIDE; GALLIUM (68GA) GOZETOTIDE; PIFLUFOLASTAT (18F)
• A study to learn more about how well elinzanetant works and how safe it is compared to placebo for the treatment of hot flashes caused by an… Ended
  2023-508265-33-00 Phase III 12 countries ELINZANETANT
• A study to learn how well finerenone works; how safe it is; how it moves into, through, and out of the body; and the effects it has on the b… Ended
  2023-504884-17-00 Phase III 17 countries FINERENONE

Showing 1–24 of 71 trials